| Course | NR 508 Advanced Pharmacology |
|---|---|
| Week | 4 |
| Paper type | Pharmacology case application paper |
| Length | About 1,120 words, 3 pages |
| Format | APA 7 student paper |
| School | Chamberlain University |
| Program | MSN |
| Updated | October 2026 |
Free sample paper for NR 508 Week 4
Zolpidem 5 mg After a Night Shift for a 67-Year-Old Unit Clerk: A Bedtime at 0830, a Drive Home Before It, Sertraline Raising Her Exposure, Gabapentin and Oxycodone Adding Sedation, and Six and a Half Hours of Sleep Where the Label Asks for Seven
Student Name
College of Nursing, Chamberlain University
NR 508: Advanced Pharmacology
Instructor Name
Month Day, Year
Zolpidem 5 mg After a Night Shift for a 67-Year-Old Unit Clerk: A Bedtime at 0830, a Drive Home Before It, Sertraline Raising Her Exposure, Gabapentin and Oxycodone Adding Sedation, and Six and a Half Hours of Sleep Where the Label Asks for Seven
The Regimen, Restated
Ms. P., 67, covers three nights a week, each 1900 to 0730, as a unit clerk in a hospital. She reports poor daytime sleep after her shifts and has been prescribed zolpidem tartrate 5 mg "at bedtime as needed." Her other medicines are sertraline 100 mg each morning for depression, gabapentin 300 mg at bedtime for diabetic neuropathy, oxycodone 5 mg as needed for knee osteoarthritis, which she takes about twice a week, and lisinopril 20 mg daily. Her estimated glomerular filtration rate is 58 mL/min/1.73 m2 and her liver tests are normal. She drives 25 minutes home after each shift and aims to sleep from about 0830 to 1500 before family responsibilities in the afternoon.
This paper takes facts about zolpidem one at a time and lands each on Ms. P., because the prescription as written is correct for a generic patient and questionable for her.
The Dose and Her Age
The prescribing information recommends an initial dose of 5 mg for women and states that elderly or debilitated patients may be especially sensitive to zolpidem, with 5 mg as the recommended dose for them (Cosette Pharmaceuticals, 2025). The lower dose for women reflects lower zolpidem clearance in women. For Ms. P., who is both a woman and 67, 5 mg is the right dose and the ceiling; the label's option to increase to 10 mg does not apply to her. Her kidney function does not change the dose, because zolpidem is cleared mainly by hepatic metabolism, and her liver tests are normal.
The American Geriatrics Society's Beers Criteria list the "Z-drug" hypnotics, zolpidem among them, as medicines to avoid in older adults because of the risk of falls, fractures, delirium and motor vehicle crashes, with only modest improvement in sleep (American Geriatrics Society Beers Criteria Update Expert Panel, 2023). For Ms. P., that is not a prohibition, but it means the prescription needs a stronger reason and a closer plan than it would at 45.
Bedtime, Hours of Sleep and the Drive Home
The label directs that zolpidem be taken only once per night, immediately before bedtime, with at least 7 to 8 hours remaining before the planned time of awakening, and warns of next-day impairment of driving and activities requiring full alertness, particularly at higher morning blood levels (Cosette Pharmaceuticals, 2025). For Ms. P., "bedtime" is 0830, after a 25-minute drive. If she takes the tablet in the hospital locker room at 0735 to fall asleep faster when she gets home, she will be driving during absorption, which the label's timing is designed to prevent. The dose must be taken at home, in bed.
Her planned sleep, 0830 to 1500, is six and a half hours, short of the label's 7 to 8. For her, either the dose day must allow a longer sleep or the drug is likely to leave her impaired at 1500, when she drives to collect her grandchildren. This is the single most important finding in the case, and it comes from her schedule, not from the pharmacology alone.
Interactions Written as Pairs
Sertraline raises zolpidem. The label states that coadministration of zolpidem and sertraline increases exposure to zolpidem (Cosette Pharmaceuticals, 2025). The direction is one way: sertraline raises zolpidem levels, not the reverse. For Ms. P., who takes sertraline 100 mg daily, a 5 mg dose of zolpidem will produce higher levels than it would in a woman her age without sertraline, which adds to the concern about a short sleep period.
Gabapentin and zolpidem add sedation. This pair is pharmacodynamic, not pharmacokinetic: neither drug changes the other's levels, but both depress the central nervous system, and the label warns that coadministration with other CNS depressants increases drowsiness and psychomotor impairment and may require dose adjustment. For Ms. P., her gabapentin is prescribed "at bedtime," which on work days will also be 0830, so both drugs will peak during the same sleep period.
Oxycodone and zolpidem add respiratory depression. The label lists opioids specifically, warning that concomitant use may increase the risk of respiratory depression. For Ms. P., who takes oxycodone about twice a week, the pair is intermittent, which makes it easy to forget. She should not take oxycodone on a day she takes zolpidem, or should be taught which one to skip.
Lisinopril and zolpidem have no meaningful interaction, and saying so is useful: it tells the reader the list was checked, not skimmed.
What the Case Did Not Say
Several facts that would change the plan are missing from the record, and each should be asked about before the first dose. The first is alcohol: the label names alcohol among the CNS depressants whose effects add to zolpidem's, and a drink to wind down after a night shift is common. The second is any history of sleepwalking or other complex sleep behaviors; the label carries a warning that these may occur after the first or any dose and require immediate discontinuation. The third is snoring or witnessed pauses in breathing, because untreated sleep apnea combined with a sedative, gabapentin and occasional oxycodone is a respiratory risk. The fourth is what she has already tried: shift-work sleep usually responds first to light control, blackout curtains and a consistent sleep window, and the label itself notes that failure of insomnia to remit after 7 to 10 days should prompt evaluation for another cause (Cosette Pharmaceuticals, 2025).
The Plan That Follows
If zolpidem is used, the plan should be specific to her: 5 mg, taken at home in bed, only on days when she can sleep at least 7 hours afterward; no oxycodone on those days; gabapentin moved to the same time only if her prescriber agrees that its dose can be taken earlier in the shift or reduced; no alcohol; and a review in two weeks to decide whether the drug is needed at all. A better first step, given her age and her other medicines, would be to treat the circadian problem directly with light and schedule measures, and to keep zolpidem for nights, or rather days, when those fail.
References
American Geriatrics Society Beers Criteria Update Expert Panel. (2023). American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 71(7), 2052-2081. https://doi.org/10.1111/jgs.18372
Cosette Pharmaceuticals. (2025). Ambien (zolpidem tartrate) tablet, film coated [Prescribing information]. DailyMed, National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=747949c5-2c91-4909-8a07-71b6826f8e97
Reading the NR 508 Week 4 instructions
The Week 4 paper asks you to apply pharmacology to a patient case. Students are usually asked for the regimen, patient factors, dosing, interactions, safety concerns, missing information and a recommended plan, with APA. Restate the regimen briefly. Take facts about the drug one at a time and apply each to this patient's age, schedule, organ function and other medicines. Write interactions as pairs and say whether each is pharmacokinetic or pharmacodynamic. Note pairs with no interaction, to show the list was checked. List what the case leaves out that would change the plan. End with a plan specific to the person, not a generic one.
Inside the NR 508 Week 4 example
The regimen section describes Ms. P.'s three nights a week from 1900 to 0730 and her poor daytime sleep. The dose section applies the label's 5 mg recommendation for women and its caution for older adults, and the Beers listing for Z-drugs. The bedtime section explains the requirement to take it immediately before bed with 7 to 8 hours remaining, and finds her planned 0830 to 1500 sleep too short. The interaction section pairs zolpidem with sertraline, gabapentin, oxycodone and lisinopril. The missing information section lists alcohol and other questions. The plan section sets 5 mg at home in bed only on days with at least 7 hours available, with changes to her other sedating medicines discussed.
Reading the NR 508 Week 4 grading rubric
Case application rubrics in NR 508 typically weigh accurate drug information, application to patient factors, interaction analysis, safety considerations, identification of missing information, a patient-specific plan and APA. Applying each fact to this patient is the row graders look for most, and the paper lands every clause on her age, schedule or medicines. Interactions are credited for being written as pairs with their type. Safety scores through the drive home and short sleep window. Missing information earns points for alcohol and other questions. The plan is credited for being specific to her. The Ambien label and the 2023 Beers Criteria support the paper. Noting that lisinopril has no interaction shows the whole list was checked.
NR 508 Week 4 help: mistakes that cost points
The largest deduction lands on a drug section that never touches the vignette, with accurate pharmacology and no mention of the person's age, schedule or other medicines. Another loss is listing interactions without saying how they work. Students also miss the timing problem in shift workers, ignore pairs with no interaction or recommend a plan that would fit anyone. If the case gives no laboratory values, say what you would want and why. The paper may recommend changing the regimen if the facts support it. Cover every agent that interacts. Send your case and an NR 508 application can land each drug fact on the patient. Check every medicine on the list, including the harmless ones.
Get a NR 508 Week 4 example written to your instructions
Send the vignette your classroom posted along with the Week 4 instructions and any required element list, and a custom example is written to that case and returned inside 24 to 48 hours, the first one free. The more of the patient detail you paste in, the more of the example can be built to land on it.
More NR 508 papers and MSN samples
- NR 508 Week 1: Pharmacokinetic Property Post
- NR 508 Week 2: Dabigatran Pharmacokinetics Write-Up
- NR 508 Week 3: Calcium Channel Blocker Class Analysis
- NR 508 Week 5: Adverse Effect Analysis
- NR 508 Week 6: Therapeutic Failure Write-up
- NR 508 Week 7: Medication Teaching Plan
- NR 508 Week 8: Pharmacology Case Paper
- NR 510 Week 4: Policy Influence Plan
- NR 506NP Week 4: NP Outcomes Evidence Review Paper
- NR 510F Week 4: Mentorship Plan for the First Year
- NR 506 Week 4: Medicare Insulin Cap Policy Analysis
NR 508 Week 4 questions, answered
The case gives no laboratory values at all. What then?
Write the gap into the paper rather than around it. Say which decision would change if the figure were low, name the value you would want and why that one, and carry on reasoning with what the vignette did supply. Markers reward this because it shows you know which numbers the pharmacology actually depends on, which a fabricated value never demonstrates.
Should the paper recommend changing the regimen?
Only as far as the prompt asks. This course is built around accounting for therapy rather than authoring it, so the safer center of gravity is what the drugs are doing and what would show it. Where a change is invited, state it as a pharmacologic consequence with the reason attached rather than as an instruction, and keep it to the end.
How many agents from the list should the paper cover?
Depth beats coverage in almost every section. Three agents worked through properly, with interactions and monitoring attached, outscores nine handled in a sentence each. Choose the ones the vignette was built around, say in a line why the rest are being set aside, and spend the length on the drugs the case was clearly assembled to raise.
Where can I find a free NR 508 Week 4 sample paper?
This page shows the complete Week 4 case application of zolpidem for a night-shift worker, with the dose, timing, interaction pairs, missing information, the plan and two references.
Why is the sleep window a problem in the NR 508 Week 4 case?
The label requires 7 to 8 hours between the dose and waking, but her planned sleep from 0830 to 1500 is only six and a half hours, which risks next-day impairment.